ArticleJournal of neuroimmunology2013

The novel HSP90 inhibitor, PU-H71, suppresses glial cell activation but weakly affects clinical signs of EAE.

Lucia Lisi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.